QIAGEN (QGEN) Submits therascreen EGFR Test to U.S. FDA

Go back to QIAGEN (QGEN) Submits therascreen EGFR Test to U.S. FDA
Qiagen NV (NYSE: QGEN) Delayed: 43.98 +1.66 (3.92%)
Previous Close $42.32    52 Week High $28.50 
Open $43.44    52 Week Low $19.94 
Day High $44.09    P/E 151.66 
Day Low $43.39    EPS $0.29 
Volume 539,105